Fifth Third Bancorp’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9M Sell
32,540
-2,556
-7% -$502K 0.01% 628
2026
Q1
$6.88M Buy
35,096
+26,233
+296% +$5.1M 0.01% 589
2025
Q4
$1.54M Sell
8,863
-720
-8% -$131K ﹤0.01% 530
2025
Q3
$1.83M Sell
9,583
-62
-0.6% -$11K 0.01% 489
2025
Q2
$1.73M Sell
9,645
-198
-2% -$34.4K 0.01% 485
2025
Q1
$1.67M Buy
9,843
+5,167
+111% +$849K 0.01% 481
2024
Q4
$705K Buy
4,676
+1,009
+28% +$157K ﹤0.01% 660
2024
Q3
$569K Buy
3,667
+60
+2% +$8.96K ﹤0.01% 747
2024
Q2
$494K Buy
3,607
+475
+15% +$65K ﹤0.01% 752
2024
Q1
$417K Buy
3,132
+46
+1% +$5.97K ﹤0.01% 813
2023
Q4
$425K Sell
3,086
-16
-0.5% -$2.1K ﹤0.01% 783
2023
Q3
$378K Sell
3,102
-525
-14% -$70K ﹤0.01% 810
2023
Q2
$510K Buy
3,627
+437
+14% +$60.2K ﹤0.01% 731
2023
Q1
$451K Buy
3,190
+322
+11% +$46.1K ﹤0.01% 764
2022
Q4
$449K Buy
2,868
+125
+5% +$18K ﹤0.01% 728
2022
Q3
$337K Sell
2,743
-257
-9% -$33.8K ﹤0.01% 803
2022
Q2
$399K Sell
3,000
-1,547
-34% -$211K ﹤0.01% 750
2022
Q1
$622K Buy
4,547
+37
+0.8% +$5.16K ﹤0.01% 662
2021
Q4
$780K Buy
4,510
+1,908
+73% +$290K ﹤0.01% 616
2021
Q3
$378K Buy
2,602
+281
+12% +$41.1K ﹤0.01% 780
2021
Q2
$306K Buy
2,321
+168
+8% +$22K ﹤0.01% 849
2021
Q1
$276K Buy
2,153
+21
+1% +$2.59K ﹤0.01% 850
2020
Q4
$254K Buy
2,132
+375
+21% +$45.7K ﹤0.01% 847
2020
Q3
$201K Buy
1,757
+69
+4% +$8.15K ﹤0.01% 867
2020
Q2
$192K Sell
1,688
-274
-14% -$29.1K ﹤0.01% 885
2020
Q1
$158K Sell
1,962
-753
-28% -$78K ﹤0.01% 910
2019
Q4
$290K Buy
2,715
+289
+12% +$30.1K ﹤0.01% 831
2019
Q3
$260K Sell
2,426
-754
-24% -$77.4K ﹤0.01% 845
2019
Q2
$324K Sell
3,180
-257
-7% -$24.7K ﹤0.01% 763
2019
Q1
$309K Buy
3,437
+587
+21% +$50.9K ﹤0.01% 755
2018
Q4
$237K Buy
2,850
+235
+9% +$22K ﹤0.01% 811
2018
Q3
$282K Buy
2,615
+2,158
+472% +$237K ﹤0.01% 799
2018
Q2
$50K Buy
457
+31
+7% +$3.23K ﹤0.01% 1319
2018
Q1
$43K Buy
426
+287
+206% +$29.4K ﹤0.01% 1384
2017
Q4
$14K Sell
139
-58
-29% -$5.5K ﹤0.01% 1720
2017
Q3
$18K Buy
197
+92
+88% +$9.77K ﹤0.01% 1620
2017
Q2
$12K Sell
105
-45
-30% -$4.76K ﹤0.01% 1682
2017
Q1
$15K Sell
150
-39
-21% -$3.72K ﹤0.01% 1623
2016
Q4
$17K Buy
189
+39
+26% +$3.36K ﹤0.01% 1651
2016
Q3
$13K Sell
150
-2,821
-95% -$237K ﹤0.01% 1755
2016
Q2
$242K Sell
2,971
-5,754
-66% -$438K ﹤0.01% 871
2016
Q1
$623K Sell
8,725
-132
-1% -$8.85K 0.01% 657
2015
Q4
$630K Sell
8,857
-263
-3% -$17.7K 0.01% 672
2015
Q3
$561K Sell
9,120
-5,827
-39% -$407K 0.01% 704
2015
Q2
$1.08M Sell
14,947
-28
-0.2% -$2.07K 0.01% 561
2015
Q1
$1.15M Buy
14,975
+5,603
+60% +$401K 0.01% 566
2014
Q4
$628K Buy
9,372
+8,621
+1,148% +$544K 0.01% 670
2014
Q3
$46K Buy
751
+40
+6% +$2.46K ﹤0.01% 1426
2014
Q2
$42K Sell
711
-50
-7% -$2.93K ﹤0.01% 1495
2014
Q1
$44K Sell
761
-298
-28% -$16K ﹤0.01% 1476
2013
Q4
$57K Buy
1,059
+432
+69% +$25.6K ﹤0.01% 1269
2013
Q3
$39K Sell
627
-6
-0.9% -$359 ﹤0.01% 1417
2013
Q2
$38K Buy
+633
New +$37.7K ﹤0.01% 1389

Other funds holding DGX

Fifth Third Bancorp's DGX Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Quest Diagnostics (DGX) stake by 7.3% in Q2 2026, selling an estimated $502K and leaving 32,540 shares worth $6.9M. The position accounts for 0.01% of the portfolio, ranked #628.

Fifth Third Bancorp first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fifth Third Bancorp held 32,540 shares of Quest Diagnostics worth $6.9M as of Q2 2026.
  • Fifth Third Bancorp sold 2,556 Quest Diagnostics shares in Q2 2026, an estimated $502K.
  • Quest Diagnostics made up 0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #628 holding.
  • Fifth Third Bancorp first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.